Cancer Treatment Centers of America partner with Allscripts and NantHealth to bring a unique system to the Cancer Treatment Centers of America health organization. Allscripts Sunrise, an electronic health record, was paired up with eviti, a clinical decision program belonging to NantHealth. Together, these programs work seamlessly to bring a clinical pathway to both, physicians and patients that offers comprehensive, pathways for more streamlined care.
The Clinical Pathways (CP) program was designed to help take any guesswork out of a patient’s direction of care after diagnosis. CP houses a full list of every cancer and it’s corresponding stages. After a patient is diagnosed, the physician can sit down with the patient and discuss the treatment options listed in the patient’s personal CP. Having a listed group of treatment possibilities eliminates physician guesswork and allows the patient to be a more active participant in their treatment options.
CP was designed with the input of government organizations, oncology associations, and peer reviewed data to offer the latest in cancer treatments and care. Also, CP is consistently updated and maintained with the latest cancer and drug information by a team of oncologists, oncology nurses, and oncology experts.
Cancer Treatment Centers of America, headquartered in Boca Raton, Florida, offers the latest in cancer care and treatment for adults. Cancer Treatment Centers of America has locations nationally in Tulsa, Philadelphia, Phoenix, Atlanta, and Chicago and have been consistently rated in the top tier of hospitals offering superior cancer treatment and aftercare.
Cancer Treatment Centers of America offers treatments that not only treat a patient’s cancer, but also their whole body, mind, and spirit. Cancer Treatment Centers of America sees a patient as a whole person and not just a diagnosis, which is why Cancer Treatment Centers of America also offers aftercare for patients who have just underwent cancer treatments. Cancer Treatment Centers of America specializes in: genomic testing, immunotherapy, chemotherapy, radiation, surgery, and precision cancer treatment.